Breast Cancer Study of Preoperative Pembrolizumab + Radiation
Clinical trial NCT03366844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03366844
- Sponsor
- Stephen Shiao
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2025-02-06
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.